Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VIDIA is a private Czech biotechnology company focused on the development, manufacture, and sale of in vitro diagnostic kits for human medicine and environmental monitoring. Founded in 1991, the company markets a broad commercial portfolio of ELISA, line immunoassay, immunofluorescence, rapid-test, and mono-test products under the VIDITEST family, with particular strength in infectious serology. VIDIA also offers automation solutions such as RoboBlot and maintains peptide and conjugate synthesis capabilities to support product development and custom work. The company collaborates with hospitals, universities, and the Academy of Sciences of the Czech Republic, and its IVD products are CE certified with ISO 9001 and ISO 13485 quality certifications. For a biotech analyst, VIDIA is best characterized as a commercial-stage diagnostics manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VIDIA.